Guideline for the quality, safety and efficacy of follow-on biological medicinal products issued by Ministry of Health, Labour and Welfare, Govermment of Japan
The translation provided here for the MHLW's notification on biosimilar products is interim translation by JGA. If any discrepancy arises between the Japanese original and the interim translation, the former is authentic.